| NCT05725018 | A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients | ACTIVE_NOT_RECRUITING | PHASE3 | 2023-04-02 | 2025-09-30 | 2025-09-30 |
| NCT04227106 | Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) | COMPLETED | PHASE3 | 2020-01-10 | 2022-10-18 | 2022-10-18 |
| NCT03315182 | Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB | TERMINATED | PHASE1, PHASE2 | 2017-10-16 | 2022-04-07 | 2022-04-07 |
| NCT01263379 | Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa | COMPLETED | PHASE1, PHASE2 | 2010-10-05 | 2022-03-09 | 2022-03-09 |
| NCT00385502 | A Trial of the Safety and Efficacy of EcoNailâ„¢ in the Treatment of Fungus Infections of the Great Toenail | COMPLETED | PHASE2 | 2006-09 | 2008-06 | 2008-06 |
| NCT00563433 | MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers | COMPLETED | PHASE3 | 1994-08 | 1996-07 | 1996-07 |
| NCT00563394 | MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers | COMPLETED | PHASE3 | 1994-08 | 1996-07 | 1996-07 |